Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ventura, J. E.
Right arrow Articles by Muñoz, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ventura, J. E.
Right arrow Articles by Muñoz, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 1795-1801
© 2002 European Renal Association-European Dialysis and Transplant Association

Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance haemodialysis

José E. Ventura1,, Norberto Tavella2, Carlos Romero2, Alicia Petraglia1, Alvaro Báez2 and León Muñoz2

1 Servicio de Asistencia Renal Integral (SARI) and 2 Departamento de Cardiología, Hospital de Clínicas, Universidad de la República, Uruguay

Background. Calcification and dysfunction of aortic and mitral valves are frequently found in chronic dialysis patients, but their influence on the development of left ventricular hypertrophy (LVH) is not well defined.

Methods. Conventional echocardiography and Doppler measurement of trans-aortic flow velocity were performed in 135 chronic haemodialysis patients, and left ventricular mass index (LVMI) and trans-valve pressure gradients were calculated. Average values of systolic, diastolic and pulse pressure (PP), interdialytic weight gain, chronic overhydration (difference between mean post-dialysis and dry weights), plasma calcium, phosphate, haemoglobin, and urea reduction ratio over the year preceding this study were obtained in every patient.

Results. Aortic valve calcification was present in 105 patients (78%), associated with stenosis in eight (6%); 39 patients (29%) had aortic regurgitation. Mitral annular calcification occurred in 35 (26%) cases and mitral regurgitation in 45 (33%). LVH was observed in 104 patients (77%). Logistic analysis revealed that only aortic valve calcification predicted LVH. LVMI was higher in patients with aortic valve calcification than in those without calcification: (mean±SD) 241±52 vs 154±64 g/m2, P=0.001. LVMI was not different between patients with normal, calcified, or regurgitating mitral valves. Patients with aortic valve calcification had higher trans-valve peak flow velocities and pressure gradients than those with non-calcified valves: 1.65±0.53 vs 1.37±0.33 m/s, P=0.01, and 12.1±8.9 vs 7.9±3.6 mmHg, P=0.01, respectively. The LVMI correlated directly with both variables (r=0.27 and r=0.24, P<0.005). Stepwise linear regression on nine covariates potentially influencing LVMI (age, body mass index, time on dialysis, systolic blood pressure, PP, chronic overhydration, haemoglobin concentration, trans-aortic flow velocity, and urea reduction ratio) showed that LVMI was independently associated with (i) PP, (ii) haemoglobin (inverse correlation), (iii) peak aortic flow velocity, and (iv) chronic overhydration (r=0.502, R2=0.252, ANOVA F-ratio=10.19, P<0.0005).

Conclusion. Our findings show that aortic valve calcification is associated with LVH in chronic haemodialysis patients, probably because valve resistance to ventricular outflow is increased as shown by trans-aortic flow velocities and pressure gradients. The effect on LVMI is independent of PP, anaemia, and overhydration.

Keywords: aortic valve calcification; haemodialysis; left ventricular hypertrophy

Correspondence and offprint requests to: Dr José E. Ventura, SARI-Ibirapita 2743, Casilla de Correo 16217, CP11600, Montevideo, Uruguay. Email: jevent{at}elsitio.net.uy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CJASNHome page
A. Y.-M. Wang, C. W.-K. Lam, M. Wang, I. H.-S. Chan, S.-F. Lui, and J. E. Sanderson
Is Valvular Calcification a Part of the Missing Link between Residual Kidney Function and Cardiac Hypertrophy in Peritoneal Dialysis Patients?
Clin. J. Am. Soc. Nephrol., October 1, 2009; 4(10): 1629 - 1636.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
S. Guvel, M. A. Pourbagher, D. Torun, T. Egilmez, A. Pourbagher, and H. Ozkardes
Calcification of the Epididymis and the Tunica Albuginea of the Corpora Cavernosa in Patients on Maintenance Hemodialysis
J Androl, September 1, 2004; 25(5): 752 - 756.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.